A preliminary prediction model of pediatric Mycoplasma pneumoniae pneumonia based on routine blood parameters by

Xuelian Peng1, Yulong Liu1, Bo Zhang1

  • 1Department of Laboratory Medicine, The Affiliated Dazu's Hospital of Chongqing Medical University, Chongqing, 402360, China.

PubMed
Abstract

Insights

This study developed an AI model using routine blood tests to accurately predict pediatric Mycoplasma pneumoniae pneumonia (MPP). The tool aids healthcare providers in diagnosing MPP, especially in underserved regions.

Area of Science:

  • Pediatric Infectious Diseases
  • Artificial Intelligence in Medicine
  • Biomarker Discovery

Background:

  • Pediatric Mycoplasma pneumoniae pneumonia (MPP) presents a significant health challenge.
  • Accurate and timely diagnosis of MPP is crucial for effective treatment.
  • Existing diagnostic methods may have limitations in accessibility and speed.

Purpose of the Study:

  • To evaluate the predictive value of routine blood parameters for pediatric MPP.
  • To develop and validate a robust ensemble artificial intelligence (AI) model for MPP identification.
  • To create a generalizable AI tool to assist healthcare providers in diagnosing MPP.

Main Methods:

  • Collected 27 features, including routine blood parameters and hs-CRP, from pediatric patients.
  • Developed an integrated prediction tool using seven machine learning (ML) algorithms.
  • Validated the AI model on internal (982 individuals) and external (195 individuals) datasets.

Main Results:

  • The Gradient Boosting Decision Tree (GBDT) model achieved high performance.
  • Demonstrated an AUC of 0.980, accuracy of 0.928, sensitivity of 0.926, and specificity of 0.929.
  • A GBDT-based AI Lab was developed for clinical use.

Conclusions:

  • The GBDT-based AI Lab tool effectively discriminates pediatric MPP using routine blood parameters.
  • The tool exhibits high sensitivity and specificity for MPP diagnosis.
  • A user-friendly AI Lab webpage facilitates healthcare access in remote areas.